Skip to main content
. 2021 Dec 1;3(1):vdab179. doi: 10.1093/noajnl/vdab179

Figure 4.

Figure 4.

Progression-free survival (PFS) (A) and overall survival (OS) (B) for patients with newly diagnosed DIPG (stratum A) and PFS (C) and OS (D) for patients with recurrent HGG, including DIPG (stratum B). For (B), the OS of a historical control cohort of patients with newly diagnosed DIPG treated at St. Jude Children’s Research Hospital from October 1992 to May 2011 who met the age criteria of this clinical trial is presented (n = 189 patients) and compared via the log-rank test.